Showing results (51-60 of 210) with videos related to
Sort By:
Pageof 21
Deutsche Medizinische Wochenschrift (1946)|November 11, 2005
[Large artery wall properties -- what is relevant for the classic management of hypertension?]M Hausberg, D Lang, M Barenbrock, et al.Medizinische Klinik (Munich, Germany : 1983)|June 13, 2000
[Alterations of arterial vessel wall properties in hyperparathyroidism]M Kosch, M Hausberg, K Kisters, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 1, 1995
Neurotransmitters and neuropeptides in the baroreceptor reflex arc: connections between the nucleus of the solitary tract and the ventrolateral medulla oblongata in the ratM Palkovits, E Mezey, M Fodor, et al.Transplantation Proceedings|April 26, 2005
Gastrointestinal-specific patient-reported outcome instruments differentiate between renal transplant patients with or without GI complicationsL Kleinman, R Faull, R Walker, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 20, 2007
High-tone external muscle stimulation in end-stage renal disease: effects on symptomatic diabetic and uremic peripheral neuropathyA Klassen, B Di Iorio, P Guastaferro, et al.Kidney International. Supplement|March 20, 1999
Hypochromic red blood cells and reticulocytesR M Schaefer, L SchaeferNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Iron monitoring and supplementation: how do we achieve the best results?R M Schaefer, L SchaeferNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Treatment with erythropoietin and loss of dialyser clearanceR M Schaefer, L SchaeferJournal of Perinatal Medicine|January 1, 1995
The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapyR M Schaefer, L SchaeferClinical Nephrology|November 15, 2000
Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysisA Gerdemann, H D Lemke, A Nothdurft, et al.Pageof 21